Medicenna Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MDNAF and buy or sell other stocks, ETFs, and their options commission-free!

About MDNAF

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. 

CEO
Fahar Merchant
CEOFahar Merchant
Employees
16
Employees16
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
2015
Founded2015
Employees
16
Employees16

MDNAF Key Statistics

Market cap
44.65M
Market cap44.65M
Price-Earnings ratio
-2.43
Price-Earnings ratio-2.43
Dividend yield
—
Dividend yield—
Average volume
24.72K
Average volume24.72K
High today
$0.6679
High today$0.6679
Low today
$0.641
Low today$0.641
Open price
$0.6572
Open price$0.6572
Volume
675.00
Volume675.00
52 Week high
$1.94
52 Week high$1.94
52 Week low
$0.60
52 Week low$0.60

People also own

Based on the portfolios of people who own MDNAF. This list is generated using Robinhood data, and it’s not a recommendation.
Ocugen, Inc
Ideanomics
Nikola
Plug Power
Lucid Group
SNDL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.